bioRxivPhysiologyPreprint
The colon is an extra-pancreatic source of glucagon: demonstration in a mouse model of pancreatectomy
Anne‐Charlotte Jarry, Johanne Le BeyeciD, André BadoiD, Jean–François GautieriD, Jean‐Pierre RivelineiD, Bertrand BlondeauiD, Ghislaine GuillemainiD, Maude Le GalliD
Abstract
Glucagon is considered as a pancreas-specific hormone. However, an extra-pancreatic source of glucagon, which secretion is inappropriately induced by oral glucose, has been suspected for years in patients with diabetes. In a mouse model of subtotal pancreatectomy, we recapitulated the abnormal secretion of glucagon in response to oral glucose observed in pancreatectomised patients and excluded the remaining pancreas as the source of glucagon. We showed that the colon can produce and secrete glucagon. Subtotal pancreatectomy resulted in an increased expression of PCSK2 protease in the colon that favors the maturation of proglucagon into glucagon over other glucagon-related peptides normally produced by enteroendocrine cells. These results identify a mechanism that could contribute to abnormal glucagon production and poor glycemic control in pancreatectomized diabetic subjects. Moreover, our findings may pave the road to new therapeutic strategies to counteract poor glucose control for patients with diabetes.
- organism: mouse
- research focus: host-pathogen & immune response
- research focus: cell signaling & trafficking
- research focus: metabolism & bioenergetics
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Reduced somatostatin signalling leads to hypersecretion of glucagon in mice fed a high fat diet
J. A. Kellard, N. J. G. Rorsman, … L. Briant·bioRxiv·Apr 7, 2020
- G6PC2 controls glucagon secretion by defining the setpoint for glucose in pancreatic α-cells
Varun Bahl, Eric Waite, … Klaus H. Kaestner·Science Translational MedicinePeer-reviewed·Jan 1, 2025
- Misrouting of Glucagon and Stathmin-2 Towards Lysosomal System of α-Cells in Glucagon Hypersecretion of Diabetes
F. Asadi, S. Dhanvantari·bioRxiv·Apr 8, 2021
- Leucine suppresses glucagon secretion from pancreatic islets by directly modulating alpha-cell cAMP
Emily R. Knuth, Hannah R. Foster, … Matthew J. Merrins·bioRxiv·Jul 31, 2023
- Paracrine control of α-cell glucagon exocytosis is compromised in human type-2 diabetes
M. Omar-Hmeadi, P.-E. Lund, … S. Barg·bioRxiv·Oct 1, 2019
- Pancreatic Gαs ablation disrupts tissue architecture and YAP signaling and unveils a compensatory regenerative response
Martina Rossotti, Juan Ignacio Burgos, … Santiago A. Rodríguez‐Seguí·bioRxiv·Apr 21, 2026